These contradictory trends are reinforced by changes we see in the market access stakeholders’ map: • Payers have an increased influence on physicians’ prescriptions. They scrutinize drugs ...
“It is time to develop a joint strategy as a community, development stakeholders, quality regulators and TPHPA. After formulating this strategy we will present it to the public for review and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback